Farnesyltransferase and Geranylgeranyltransferase I: Structures, Mechanism, Inhibitors and Molecular Modeling.

Mingyun Shen,Peichen Pan,Youyong Li,Dan Li,Huidong Yu,Tingjun Hou

DOI: https://doi.org/10.1016/j.drudis.2014.10.002

IF: 8.369

2014-01-01

Drug Discovery Today

Abstract:Farnesyltransferase (FTase) and geranylgeranyltransferase type I (GGTase-I) have crucial roles in the post-translational modifications of Ras proteins and, therefore, they are promising therapeutic targets for the treatment of various Ras-induced cancers and several other kinds of diseases. In this review, we provide an overview of the structures and biological functions of FTase and GGTase-I. Then, we summarize the typical inhibitors of FTase and GGTase-I, and highlight the drug candidates in clinical trials. In addition, we survey some recent advances in computer-aided drug design (CADD) and molecular modeling studies of FTase and GGTase-I.